IDYA: IDEAYA Biosciences, Inc. Stock

by  •  • Comments Off on IDYA: IDEAYA Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,416.35
Enterprise Value ($M) 1,331.98
Book Value ($M) 1,180.42
Book Value / Share 13.48
Price / Book 1.20
NCAV ($M) 624.77
NCAV / Share 7.14
Price / NCAV 2.27

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 14.97
Current Ratio 14.97

Balance Sheet (mrq) ($M)
Current Assets 689.71
Assets 1,124.09
Liabilities 64.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.00
Operating Income -326.98
Net Income -274.48
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -247.58
Cash from Investing -502.56
Cash from Financing 677.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A BlackRock, Inc. 8.10 -14.87
02-14 13G/A Janus Henderson Group Plc 6.80 13.47
11-14 13G/A Price T Rowe Associates Inc /md/ 4.80 12.51
11-14 13G/A Biotechnology Value Fund L P 1.70 -59.47
11-12 13G/A Fmr Llc 14.96 54.84

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 283,218 1,455,515 19.46
2025-04-16 228,774 1,069,041 21.40
2025-04-15 229,685 930,203 24.69
2025-04-14 346,061 1,277,424 27.09

(click for more detail)

Similar Companies
HUMA – Humacyte, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc. IFRX – InflaRx N.V.
IGMS – IGM Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io